CANADA LIFE ASSURANCE Co
InsurancePosition in TGTX — Tg Therapeutics, Inc.
CIK 1046192
WINNIPEG, A2
Position in TGTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,789,172
+$213,910 QoQ
Shares Held
114,063
-4.9% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $291,138,583 across 78 Biotechnology names. TGTX ranks #17 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
192,144 | $85,799,981 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,886 | $60,950,479 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,255 | $18,943,961 | |
| 4 | INCY |
Incyte Corp
|
111,609 | $10,504,639 | |
| 5 | INSM |
INSMED Inc
|
53,890 | $8,812,092 | |
| 6 | ARGX |
Argenx SE
|
11,567 | $8,446,801 | |
| 7 | MRNA |
Moderna, Inc.
|
148,181 | $7,527,594 | |
| 8 | EXEL |
Exelixis, Inc.
|
167,451 | $7,181,973 |
All Filings in TGTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,789,172 | 114,063 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,575,262 | 119,935 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,778,759 | 132,284 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $4,206,799 | 116,888 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $4,625,572 | 117,311 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,871,973 | 128,637 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,096,087 | 132,368 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $257,492 | 14,474 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $189,683 | 12,471 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $213,004 | 12,471 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $104,257 | 12,471 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $138,383 | 5,571 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $100,497 | 6,682 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $79,048 | 6,682 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $39,557 | 6,682 | Shares | Sole | 2022-11-01 | |
| 2022-03-31 | $63,545 | 6,682 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $126,958 | 6,682 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $222,376 | 6,682 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $259,194 | 6,682 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $319,951 | 6,638 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $381,774 | 7,339 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $196,391 | 7,339 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $103,166 | 5,296 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $53,037 | 5,390 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||